Copyright
©The Author(s) 2015.
World J Gastroenterol. Nov 21, 2015; 21(43): 12403-12409
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12403
Published online Nov 21, 2015. doi: 10.3748/wjg.v21.i43.12403
Table 3 Postoperative therapy and overall survival n (%)
| Total | Acute setting | Elective setting | P value | |
| n = 40 | n = 15 | n = 25 | ||
| Treatment | 0.04 | |||
| Resection alone | 12 (30) | 8 (53) | 4 (16) | |
| Resection and chemotherapy | 19 (47) | 4 (27) | 15 (60) | |
| Resection, chemotherapy and SCT | 9 (13) | 3 (20) | 6 (24) | |
| Death | 26 (65) | 12 (80) | 14 (56) | 0.12 |
| Overall survival (mo) | 15 | 8 | 19 | 0.05 |
| 1-yr survival | 57% | 40% | 67% | |
| 5-yr survival | 29% | 18% | 34% |
- Citation: van de Water JM, Nijeboer P, de Baaij LR, Zegers J, Bouma G, Visser OJ, van der Peet DL, Mulder CJ, Meijerink WJ. Surgery in (pre)malignant celiac disease. World J Gastroenterol 2015; 21(43): 12403-12409
- URL: https://www.wjgnet.com/1007-9327/full/v21/i43/12403.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i43.12403